Labiotech.eu

News and Trends 23 Apr 2020

Mogrify Teams Up With Sangamo To Streamline Cell Immunotherapies

The UK cell conversion startup Mogrify and the US genomic medicine company Sangamo have reached an exclusive license agreement that could allow Sangamo to scale up the production of off-the-shelf Treg cell therapies for inflammatory and autoimmune diseases. Under the terms of the agreement, Mogrify will receive an undisclosed upfront payment from Sangamo and will […]

April 23, 2020 - 3 minutesmins - By Laura Cowen

Orchard therapeutics gene therapy header

News and Trends 23 Apr 2020

Sofinnova Invests €20M in Three Italian Rare Disease Biotechs

The French VC firm Sofinnova Partners has invested €20M in three Italian biotech companies via its Telethon Fund, which focuses on firms developing treatments for rare diseases. The deals by the Sofinnova Telethon Fund were made over the last several months. The companies the Fund invested in — Genespire, Epsilen Bio, and PinCell — are […]

April 23, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 22 Apr 2020

€10M Series A Boosts Cancer Immunotherapy Hitting Tumor Sugar Coating

The French startup Phost’in Therapeutics has raised €10.3M to take its cancer immunotherapy drug against solid tumors into clinical trials within a year. Led by the US-Japanese venture capital firm Remiges Ventures, the Series A round also included contributions from Japanese investment firm ANRI and French private equity investor Irdi Soridec Gestion. The cash injection […]

April 22, 2020 - 3 minutesmins - By Anita Chakraverty

News and Trends 21 Apr 2020

Idorsia’s Drug Improves Sleep in First Phase III Trial for Insomnia

The Swiss pharmaceutical company Idorsia has announced that its drug candidate daridorexant significantly improved sleep onset, sleep quality, and daytime functioning of insomnia patients in a pivotal phase III trial. The trial recruited 930 adult patients with insomnia. The company used a technique called polysomnography to measure the time taken to fall asleep and sleep […]

April 21, 2020 - 3 minutesmins - By Karen O’Hanlon Cohrt

In Depth 20 Apr 2020

How Has Coronavirus Affected Europe’s Biotech Stocks?

The information flow about the coronavirus pandemic is truly electrifying, with big public market swings in the life sciences industry. That said, exactly what sort of impact is the disease known as Covid-19 having on biotech stocks? In the last few months, the Covid-19 pandemic situation has rocked the stock markets, causing intense swings across […]

April 20, 2020 - 12 minutesmins - By Carlos de Rojas

News and Trends 17 Apr 2020

French Biotech Licenses Microbiome Therapeutic to Treat Mood Disorders

The microbiome company LNC Therapeutics has entered into a licensing agreement to use a specific strain of gut bacteria for the treatment of mood disorders such as depression and anxiety. The agreement was made with the National Research Council (CSIC) in Spain, and gives LNC Therapeutics exclusive research, manufacturing, and commercialization rights of the microbiome-based […]

April 17, 2020 - 3 minutesmins - By Laura Cowen

News and Trends 17 Apr 2020

Is New Enzyme Technology Key to Solving Society’s Plastic Problem?

A new type of enzyme developed by the French company Carbios can break down more than 90% of the plastic PET, commonly used to make plastic bottles, and the byproducts can then be recycled into new PET. But how far does this go towards solving our plastic waste problem? PET, or polyethylene terephthalate, comprises around […]

April 17, 2020 - 4 minutesmins - By Helen Albert

Startup Scout 17 Apr 2020

Amphista Therapeutics Is Silencing Disease Proteins to Treat Cancer

Amphista Therapeutics, based in Glasgow, Scotland, is the latest company to develop drugs called PROTACs, which are designed to make the cell degrade harmful proteins to treat cancer. Small molecule drugs have shown incredible potential for the treatment of cancer by blocking harmful proteins in the cell. However, many promising protein targets for cancer treatments […]

April 17, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 16 Apr 2020

Irish Biotech Raises €18M to Develop Non-Viral Cell Therapy Technology

The Irish company Avectas has closed a Series C round to develop cell therapies that don’t need viral vectors — a common bottleneck in cell therapy manufacturing. The fundraise of approximately €18M brings Avectas’ total equity funding to around €37M. The round was led by the company’s current shareholders, which include the serial life sciences […]

April 16, 2020 - 2 minutesmins - By Jonathan Smith

neurofibromatosis healx ai drug repurposing

News and Trends 15 Apr 2020

Healx Deploys AI Drug Discovery Technology Against Rare Nerve Disease

The AI-driven drug repurposing company Healx has teamed up with the global Children’s Tumor Foundation (CTF) to develop new treatments for the genetic disease neurofibromatosis type 1, right after the FDA approved the first-ever drug for the condition. In the collaboration, the UK biotech will use its AI-driven pharmacology expertise to speed a candidate drug […]

April 15, 2020 - 3 minutesmins - By Jonathan Smith

Interview 15 Apr 2020

Investing in the Microbiome in the Age of Covid-19 and Beyond

For Isabelle de Cremoux, CEO and Managing Partner at Seventure Partners, 2020 was going to be an important year for microbiome research. However, the global coronavirus pandemic arrived, presenting one of the greatest unforeseen challenges in human history. I spoke to her about the microbiome field’s progress and the legacy of the Covid-19 pandemic going […]

April 15, 2020 - 7 minutesmins - By Larissa Warneck-Silvestrin

Expert Advice 13 Apr 2020

Need Funding to Fight Coronavirus? These Initiatives Have You Covered

As coronavirus disease continues to take its devastating toll across the globe, there is a clear need for new strategies to curb it. Thankfully, initiatives are springing up around the world that can support European startups in the search for new methods of diagnosis, treatment, and prevention. Coronavirus disease, also known as Covid-19, is wreaking […]

April 13, 2020 - 8 minutesmins - By External Contributor

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Mogrify Teams Up With Sangamo To Streamline Cell Immunotherapies

Sofinnova Invests €20M in Three Italian Rare Disease Biotechs

€10M Series A Boosts Cancer Immunotherapy Hitting Tumor Sugar Coating

Idorsia’s Drug Improves Sleep in First Phase III Trial for Insomnia

How Has Coronavirus Affected Europe’s Biotech Stocks?

French Biotech Licenses Microbiome Therapeutic to Treat Mood Disorders

Is New Enzyme Technology Key to Solving Society’s Plastic Problem?

Amphista Therapeutics Is Silencing Disease Proteins to Treat Cancer

Irish Biotech Raises €18M to Develop Non-Viral Cell Therapy Technology

Healx Deploys AI Drug Discovery Technology Against Rare Nerve Disease

Investing in the Microbiome in the Age of Covid-19 and Beyond

Need Funding to Fight Coronavirus? These Initiatives Have You Covered

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!